International diversification remains a central theme for investors seeking to reduce concentration in U.S. equities. CWI and VXUS are two of the most recognizable vehicles for achieving that goal, yet they are not identical. The CWI fund (SPDR MSCI ACWI ex-US ETF) offers exposure to large- and mid-cap companies outside the United States, while VXUS (Vanguard Total International Stock ETF) spans the entire global market cap spectrum outside the U.S. Because they compete directly for the same allocation in a portfolio, comparing their structure, cost, and exposure profile helps investors determine which better fits a core international holding. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
CWI is a passively managed ETF that seeks to track the MSCI ACWI ex USA Index, a free float-adjusted market-capitalization benchmark covering developed and emerging markets excluding the United States. The fund holds roughly 1,100 securities, limiting itself to large- and mid-cap companies, and carries a 0.30% expense ratio.
Its top holdings are dominated by global technology leaders, including TSM (Taiwan Semiconductor), Samsung Electronics, ASML (ASML Holding), SK hynix, and HSBC (HSBC Holdings), alongside Tencent, RY (Royal Bank of Canada), Roche, and Novartis. Sector-wise, the fund is tilted toward financials (around 25%), technology (roughly 22%), and industrials (about 11%), with smaller positions in materials, healthcare, and consumer cyclicals. Because it excludes small caps and uses an optimized sampling approach, CWI is best understood as a concentrated, large-cap-oriented gateway to international equities.
VXUS is a passively managed ETF that tracks the FTSE Global All Cap ex US Index, a benchmark covering approximately 98% of the world's investable market capitalization outside the United States. With roughly 8,800 holdings and an expense ratio of just 0.05%, it is one of the broadest and least expensive international funds available.
Its largest positions overlap significantly with CWI, including TSM (Taiwan Semiconductor), Samsung Electronics, SK hynix, ASML, Tencent, HSBC, Roche, Shell plc, RY (Royal Bank of Canada), and Novartis. However, because VXUS includes small-cap stocks across developed and emerging markets, its top-ten concentration is lower, and its breadth is dramatically greater. Sector exposure is led by financials (around 23%), technology (about 21%), and industrials (roughly 15%). This all-cap structure makes VXUS a more complete representation of the total international market.
Both ETFs sit at the center of several overlapping macro themes. International equities have drawn renewed attention as investors evaluate stretched U.S. valuations and seek geographic diversification. A meaningful share of each fund's performance is tied to global technology and semiconductor supply chains, particularly the advanced chipmakers and memory manufacturers based in Taiwan and South Korea. At the same time, both funds carry significant exposure to financials and industrials, linking them to global interest-rate expectations, credit conditions, and the manufacturing cycle. Emerging-market exposure — roughly a quarter of each portfolio — adds sensitivity to currency movements, commodity prices, and Chinese policy. Key risks include U.S. dollar strength, which can erode international returns, and geopolitical tensions affecting global trade.
Over recent market cycles, CWI and VXUS have moved in close tandem, reflecting their shared ex-U.S. mandate and overlapping mega-cap holdings. CWI, with its heavier tilt toward large-cap technology and semiconductors, has tended to show marginally higher volatility and greater responsiveness to tech-sector rotation and artificial-intelligence-driven demand. VXUS, by contrast, has offered a smoother relative positioning due to its broader base of thousands of smaller companies and lower concentration in any single theme. On cost, VXUS holds a clear structural edge: its 0.05% expense ratio is six times lower than CWI's 0.30%, a difference that compounds meaningfully over multi-year horizons. For investors focused on cost efficiency and total-market representation, VXUS generally represents the more robust relative positioning, while CWI may appeal to those seeking a more concentrated large-cap international tilt.
Weighing structural strength, cost efficiency, diversification profile, and trend consistency, Tickeron's AI would likely favor VXUS over CWI in the current environment. VXUS offers a materially lower expense ratio (0.05% versus 0.30%), far broader diversification across roughly 8,800 holdings including small caps, and superior liquidity as one of the largest international ETFs. While CWI provides a more concentrated large-cap exposure that can outperform during pronounced technology rallies, that concentration also introduces greater single-theme risk. For most investors seeking a durable, low-cost core international allocation, the AI's probabilistic assessment tilts toward VXUS for its combination of breadth, efficiency, and structural consistency.
In my own research process, I frequently rely on Tickeron’s AI Screener to run quick side-by-side checks on funds like these. The tool lets me apply filters for expense ratios, holding counts, sector weights, and performance trends in one place, which helps surface the structural differences without manual number-crunching. It has become a practical step when I want to confirm how one ETF stacks up against peers before finalizing an allocation decision.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
CWI saw its Momentum Indicator move below the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In 68 of the 86 cases, the stock moved further down in the following days. The odds of a decline are at 79%.
The Moving Average Convergence Divergence Histogram (MACD) for CWI turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 37 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CWI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for CWI entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where CWI advanced for three days, in 275 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
CWI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows